Acute depletion of heme by succinylacetone alters vascular responses but does not induce hypertension

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 9, 2008, Pages 613-619

  Soong, Jonathan ^a   Adams, Michael A ^a   Nakatsu, Kanji ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Blood vessels; Heme synthesis; Succinyl acetone

Indexed keywords

6 (2 HYDROXY 1 METHYL 2 NITROSOHYDRAZINO) N METHYL 1 HEXANAMINE; ACETYLCHOLINE; CARBON MONOXIDE; CYCLIC GMP; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HEME; HEME OXYGENASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; PORPHOBILINOGEN SYNTHASE; PORPHYRIN; PROSTACYCLIN; SUCCINYLACETONE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; DRUG SENSITIVITY; ENZYME ACTIVITY; HEME SYNTHESIS; HYPERTENSION; KIDNEY MICROSOME; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; ENZYME INHIBITORS; HEME; HEME OXYGENASE (DECYCLIZING); HEPTANOATES; HYPERTENSION; MALE; MICROSOMES; NITRIC OXIDE SYNTHASE; PORPHOBILINOGEN SYNTHASE; PORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 50849108192     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-064     Document Type: Article

References (29)

1. Andersson, C., and Lithner, F. 1994. Hypertension and renal disease in patients with acute intermittent porphyria. J. Intern. Med. 236: 169-175. PMID:8046316.
2. Batuman, V., Landy, E., Maesaka, J.K., and Wedeen, R.P. 1983. Contribution of lead to hypertension with renal impairment. N. Engl. J. Med. 309: 17-21. PMID:6406892.
3. Brandes, R.P., Kim, D., Schmitzwinnenthal, F., Amidi, M., Godecke, A., Mulsch, A., and Busse, R. 2000. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension, 35: 231-236. PMID:10642303.
4. Brien, J.F., Reynolds, J.D., Cunningham, M.A., Parr, A.M., Waddock, S., and Kalisch, B.E. 1995. Nitric oxide synthase activity in the hippocampus, frontal cerebral cortex, and cerebellum of the guinea pig: ontogeny and in vitro ethanol exposure. Alcohol, 12: 329-333. doi:10.1016/0741-8329(95)00006- D. PMID:7546328.
5. Carpenter, J.R. 1986. A method for presenting and comparing dose-response curves. J. Pharmacol. Methods, 15: 283-303. doi:10.1016/0160-5402(86) 90009-4. PMID:2873270.
6. Church, S.E., McColl, K.E., Moore, M.R., and Youngs, G.R. 1992. Hypertension and renal impairment as complications of acute porphyria. Nephrol. Dial. Transplant. 7: 986-990. PMID:1331893.
7. Cook, M.N., Nakatsu, K., Marks, G.S., McLaughlin, B.E., Vreman, H.J., Stevenson, D.K., and Brien, J.F. 1995. Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation. Can. J. Physiol. Pharmacol. 73: 515-518. PMID:7671194.
8. Friebe, A., Mergia, E., Dangel, O., Lange, A., and Koesling, D. 2007. Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A. 104: 7699-7704. doi:10.1073/pnas.0609778104. PMID:17452643.
9. Gordon, N. 1999. The acute porphyrias. Brain Dev. 21: 373-377. doi:10.1016/S0387-7604(99)00041-8. PMID:10487469.
10. Harlan, W.R., Landis, J.R., Schmouder, R.L., Goldstein, N.G., and Harlan, L.C. 1985. Blood lead and blood pressure. relationship in the adolescent and adult US population. JAMA, 253: 530-534. doi:10.1001/jama.253.4.530. PMID:3968785.
11. Heydari, A., Norouzzadeh, A., Khoxhbaten, A., Asgari, A., Ghasemi, A., Najafi, S., and Badalzadeh, R. 2006. Effects of short-term and subchronic lead poisoning on nitric oxide metabolites and vascular responsiveness in rat. Toxicol. Lett. 166: 88-94. doi:10.1016/j.toxlet.2006.05.014. PMID:16860498.
12. Jaronczyk, K., Bui, L., Soong, J.M., McLaughlin, B.E., Marks, G.S., Brien, J.F., and Nakatsu, K. 2004. The source of heme for vascular heme oxygenase II: de novo heme biosynthesis in rat aorta. Can. J. Physiol. Pharmacol. 82: 218-224. doi:10.1139/y04-015. PMID:15181459.
13. Johnson, R.A., and Freeman, R.H. 1992. Sustained hypertension in the rat induced by chronic blockade of nitric oxide production. Am. J. Hypertens. 5: 919-922. PMID:1285942.
14. Johnson, R.A., Lavesa, M., Askari, B., Abraham, N.G., and Nasjletti, A. 1995. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension, 25: 166-169. PMID:7843765.
15. Johnson, F.K., Durante, W., Peyton, K.J., and Johnson, R.A. 2003. Heme oxygenase inhibitor restores arteriolar nitric oxide function in Dahl rats. Hypertension, 41: 149-155. doi:10.1161/01.HYP.0000046923.52222.58. PMID:12511545.
16. Kimura, K.A., Parr, A.M., and Brien, J.F. 1996. Effect of chronic maternal ethanol administration on nitric oxide synthase activity in the hippocampus of the mature fetal guinea pig. Alcohol. Clin. Exp. Res. 20: 948-953. doi:10.1111/j.1530-0277.1996.tb05276.x. PMID:8865973.
17. Kinobe, R.T., Vlahakis, J.Z., Vreman, H.J., Stevenson, D.K., Brien, J.F., Szarek, W.A., and Nakatsu, K. 2006. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms. Br. J. Pharmacol. 147: 307-315. doi:10.1038/sj.bjp.0706555.
18. Li, H., and Forstermann, U. 2000. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190: 244-254. doi:10.1002/(SICI) 1096-9896(200002)190:3〈244::AID-PATH575〉3.0.CO;2-8. PMID:10685059.
19. Maren, T.H., Ellison, A.C., Fellner, S.K., and Graham, W.B. 1966. A study of hepatic carbonic anhydrase. Mol. Pharmacol. 2: 144-157. PMID:4955650.
20. Martin, C.J., Werntz, C.L., and Ducatman, A.M. 2004. The interpretation of zinc protoporphyrin changes in lead intoxication: a case report and review of the literature. Occup. Med. (Lond.), 54: 587-591. doi:10.1093/occmed/ kqh123. PMID:15576877.
21. Moncada, S., Rees, D.D., Schulz, R., and Palmer, R.M. 1991. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. U.S.A. 88: 2166-2170. doi:10.1073/pnas.88.6.2166. PMID:1848694.
22. Morrison, G.R. 1965. Fluorometric microdetermination of heme protein. Anal. Chem. 37: 1124-1126. doi:10.1021/ac60228a014. PMID:14341592.
23. Papapetropoulos, A., Abou-Mohamed, G., Marczin, N., Murad, F., Caldwell, R.W., and Catravas, J.D. 1996a. Downregulation of nitrovasodilator- induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta. Br. J. Pharmacol. 118: 1359-1366. PMID:8832057.
24. Papapetropoulos, A., Go, C.Y., Murad, F., and Catravas, J.D. 1996b. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br. J. Pharmacol. 117: 147-155. PMID:8825356.
25. Pirkle, J.L., Schwartz, J., Landis, J.R., and Harlan, W.R. 1985. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am. J. Epidemiol. 121: 246-258. PMID:4014119.
26. Thompson, K.E., Friberg, P., and Adams, M.A. 1992. Vasodilators inhibit acute a1-adrenergic receptor-induced trophic responses in the vasculature. Hypertension, 20: 809-815. PMID:1360448.
27. Tschudy, D.P., Hess, R.A., and Frykholm, B.C. 1981. Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid. J. Biol. Chem. 256: 9915-9923. PMID:7275988.
28. Victery, W. 1988. Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environ. Health Perspect. 78: 71-76. doi:10.2307/3430504. PMID:3060353.
29. Vreman, H.J., and Stevenson, D.K. 1988. Heme oxygenase activity as measured by carbon monoxide production. Anal. Biochem. 168: 31-38. doi:10.1016/0003-2697(88)90006-1. PMID:3364715.